Anthony Chi, MD

Articles by Anthony Chi, MD

In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD

ByMonica Peravali, MD,Archana Jadhav, MD,Anthony Chi, MD

May 28th 2026

Drs Chi, Peravali, and Jadhav discuss the practical advantages and clinical implications of implementing in-house NGS testing for patients with NSCLC.

Latest Updated Articles

In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD
May 28th 2026

Anthony Chi, MD

Articles by Anthony Chi, MD

In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD

Latest Updated Articles

Trending on OncLive

FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer

Exploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance

Dostarlimab Monotherapy Elicits Responses in First-Line PD-L1-Positive HNSCC

FDA Grants Accelerated Approval to RP1 Plus Nivolumab for Advanced Melanoma After Anti–PD-1 Therapy

Dr Bazhenova on the Optimal Positioning of ADCs in Lung Cancer